Decoding biology to end disease
Synteny builds the
AI platform to
power disease discoveries
from immune data

Team

We are a world-class
team of builders across computer science, immunology, mathematics
and engineering.

Lilly Wollman

Co-founder & CEO

Jamie Blundell

Co-Founder & Chief Scientific Officer

Neil Dalchau

Chief Research Officer

Joshua Meyers

Protein Engineering AI Lead

Aaron Sim

Head of AI

Alex Powlesland

Head of Discovery and Translational Technologies

Advisors

An inspiring group of advisors help us
grow the most
impactful company.

Julien Cornebise

Machine Learning & Artificial Intelligence

Daniel Fisher

Immune system dynamics and evolution of cancers

Jennifer Carter

Precision oncology & commercial strategy

Steve Crossan

Product, strategy and data generation

Bianca Dumitrascu

Machine Learning & Artificial Intelligence

Benny Chain

Computational Immunology

Partners

MRC Clinical
Trials Unit at UCL
MRC Clinical
Trials Unit at UCL